Filter by: patients
What is Interferon beta-1b SubQ Injection?

Interferon beta-1b is a drug in the interferon family used to treat multiple sclerosis. It is administered by sub-cutaneous injection and has been shown to slow the advance of the affliction as well as reduce the frequency of attacks.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
MS (Multiple Sclerosis) 1306 396 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 23 6 Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
General health 13 7 Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Fatigue 11 5 Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Walking problems 10 3 Efficacy_moderate Efficacy_none Efficacy_cant_tell
Improve mobility 7 3 Efficacy_moderate Efficacy_slight Efficacy_none

See all 982 patients currently taking Interferon beta-1b SubQ Injection

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
75
Moderate
118
Mild
157
None
69

Commonly reported side effects, conditions, and hospitalizations associated with Interferon beta-1b SubQ Injection

Flu like symptoms 125
Injection site pain 87
Bruising 70
Headaches 59
Feel lousy 57
Depressed mood 48
See all 133 reported side effects See top 6 reported side effects

Reported Dosages

Frequently reported dosages based on patients currently taking Interferon beta-1b SubQ Injection. See all 94 dosages

  daily weekly 0.3 mg weekly 0.25 mg 0.25 mg every other day 0.3 mg 0.3 mg every other day 0.3 mg daily 1 mg every other day 1 mg
  8 Number of Patients: 8 8 Number of Patients: 8 11 Number of Patients: 11 9 Number of Patients: 9 9 Number of Patients: 9 42 Number of Patients: 42 582 Number of Patients: 582 80 Number of Patients: 80 25 Number of Patients: 25 21 Number of Patients: 21  

Reported Stop Reasons

Why Patients Stopped Taking Interferon beta-1b SubQ Injection (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 269   Side effects too severe: 38%
Did not seem to work 247   Did not seem to work: 35%
Doctor's advice 241   Doctor's advice: 34%
Other 127   Other: 18%
Expense 25   Expense: 4%
Change in health plan coverage 22   Change in health plan coverage: 3%
Personal research 14   Personal research: 2%
Course of treatment ended 14   Course of treatment ended: 2%
Not indicated 13   Not indicated: 2%

See all 680 patients who’ve stopped taking Interferon beta-1b SubQ Injection

Currently Taking Interferon beta-1b SubQ Injection

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Interferon beta-1b SubQ Injection

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Interferon beta-1b SubQ Injection

Always
317 76%
Usually
82 20%
Sometimes
8 2%
Never
12 3%

Burden

Difficulty being on treatment

Burden of Interferon beta-1b SubQ Injection

Very
44 11%
Somewhat
121 29%
A little
145 35%
Not at all
109 26%

Cost

Paid out of pocket

Cost of Interferon beta-1b SubQ Injection

$200+
28 9%
$100-199
17 5%
$50-99
50 16%
$25-49
75 24%
< $25
145 46%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 12, 2012.